title: Effects of toxic doses of glutamate on Cu-Zn and Mn/superoxide dismutases activities in human glioma cell lines.
abstract: Recent research has implicated glutamate in the growth and invasive migration of gliomas. Superoxide dismutase (SOD) is involved in excitotoxicity and may influence cellular proliferative status. Thus, this study investigated the effects of gliotoxic doses of glutamate on Cu-Zn and Mn/SODs activities in human glioma cell lines. To this end, glioma cell lines (U87MG, U138MG and U251MG) were treated with glutamate (5-200 mM) during 48 h. Then, cell viability assays, clonogenic assay and Cu-Zn and Mn/SODs activities of the cell lines were performed. IC50values of glutamate were similar for both U87MG and U138MG cells (56 and 69 mM, respectively), while a higher value was detected for U251MG cells (110 mM). In the long term, 14 days after glutamate was removed from the culture media, cells showed partial or complete recovery. The effects of glutamate treatment on Cu-Zn and Mn/SODs activities varied among the distinct cell lines. While acute treatment with toxic doses of glutamate caused a significant decrease in the Cu-Zn/SOD activity of U138MG and U251MG cells, it did not affect Cu-Zn/SOD activity in U87MG cells. Only in U251MG cells, acute glutamate treatment decreased significantly Mn/SOD activity. In the long term (14 days after the 48 h treatment), glutamate did not affect either Cu-Zn or Mn/SODs activities. Thus, it may be suggested that SOD vulnerability to glutamate-mediated effects may be related to distinct tumoral cell behavior.
authors.affiliation: Centro de Pesquisas em Ciências Médicas, Universidade Luterana do Brasil (ULBRA), Rua Miguel Tostes, 101, Prédio 22, 5 andar, Bairro São Luis, Canoas/RS, CEP: 9240-280 Brasil. regner@uol.com.br
authors.forename: Andrea
authors.initials: A
authors.lastname: Regner
authors.forename: Daniel Pretto
authors.initials: DP
authors.lastname: Schunemann
authors.forename: Ivana
authors.initials: I
authors.lastname: Grivicich
authors.forename: Celito Luis
authors.initials: CL
authors.lastname: Diel
authors.forename: Caroline Brunetto
authors.initials: CB
authors.lastname: Farias
authors.forename: Giovana
authors.initials: G
authors.lastname: Kowaleski
authors.forename: Edlaine
authors.initials: E
authors.lastname: Mondadori
authors.forename: Gilberto
authors.initials: G
authors.lastname: Schwartsmann
authors.forename: Adriana Brondani
authors.initials: AB
authors.lastname: da Rocha
mesh_terms: D000704:Analysis of Variance; D000970:Antineoplastic Agents / Q000494:pharmacology; D045744:Cell Line, Tumor; D002470:Cell Survival; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005910:Glioma / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D018698:Glutamic Acid / Q000494:pharmacology*; D006801:Humans; D020128:Inhibitory Concentration 50; D009423:Nervous System Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D009498:Neurotoxins / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009498:Neurotoxins; D018698:Glutamic Acid; D013482:Superoxide Dismutase
references.citation: J Neurochem. 2000 Oct;75(4):1557-65
references.pmid: 10987836
references.citation: J Neurosci. 1999 Dec 15;19(24):10767-77
references.pmid: 10594060
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: Int J Cancer. 1997 Oct 9;73(2):187-92
references.pmid: 9335440
references.citation: J Neurosci Res. 1998 May 1;52(3):307-21
references.pmid: 9590439
references.citation: J Neurosci. 1996 Aug 15;16(16):5073-81
references.pmid: 8756437
references.citation: J Neurotrauma. 2001 Aug;18(8):783-92
references.pmid: 11526984
references.citation: J Neurochem. 1985 Oct;45(4):1186-92
references.pmid: 2863331
references.citation: Prog Neurobiol. 2001 Sep;65(1):1-105
references.pmid: 11369436
references.citation: Cancer Res. 2001 Aug 15;61(16):6082-8
references.pmid: 11507057
references.citation: J Neuroimmunol. 1997 Sep;78(1-2):152-61
references.pmid: 9307240
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8530-5
references.pmid: 8710904
references.citation: Physiol Rev. 1998 Jan;78(1):99-141
references.pmid: 9457170
references.citation: Neurosurgery. 2000 Feb;46(2):419-30
references.pmid: 10690732
references.citation: Int J Dev Neurosci. 2000 Apr-Jun;18(2-3):289-97
references.pmid: 10715583
references.citation: J Neurosci Methods. 2002 Jan 15;113(1):99-110
references.pmid: 11741727
references.citation: Prog Neurobiol. 2000 Dec;62(6):561-81
references.pmid: 10880851
references.citation: J Neurochem. 2000 Apr;74(4):1666-73
references.pmid: 10737625
references.citation: Cancer Res. 2003 Mar 15;63(6):1297-303
references.pmid: 12649190
references.citation: Exp Neurol. 1999 Aug;158(2):428-36
references.pmid: 10415149
references.citation: Annu Rev Neurosci. 1990;13:171-82
references.pmid: 1970230
references.citation: Cancer Res. 2000 Jul 15;60(14):3927-39
references.pmid: 10919671
references.citation: FEBS Lett. 2001 May 18;497(1):1-5
references.pmid: 11376653
references.citation: J Neurosci Res. 1999 Aug 15;57(4):417-28
references.pmid: 10440891
references.citation: Brain Res. 1998 Dec 14;814(1-2):164-70
references.pmid: 9838093
references.citation: J Neurochem. 2000 Sep;75(3):939-45
references.pmid: 10936174
references.citation: J Neurooncol. 1996 Aug;29(2):121-8
references.pmid: 8858516
references.citation: N Engl J Med. 1994 Mar 3;330(9):613-22
references.pmid: 7905600
references.citation: Brain Res. 1997 Aug 22;766(1-2):285-8
references.pmid: 9359618
references.citation: Am J Physiol. 1997 Nov;273(5 Pt 2):R1771-8
references.pmid: 9374822
references.citation: Neurosurgery. 1997 Nov;41(5):1146-50; discussion 1151
references.pmid: 9361070
references.citation: Eur J Pharmacol. 2002 Jul 5;447(2-3):239-46
references.pmid: 12151015
references.citation: J Cereb Blood Flow Metab. 2000 Feb;20(2):359-68
references.pmid: 10698074
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6372-7
references.pmid: 11331750
references.citation: Nat Med. 2001 Sep;7(9):1010-5
references.pmid: 11533703
references.citation: J Biol Chem. 1997 Jul 25;272(30):18515-7
references.pmid: 9228011
references.citation: Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3113-7
references.pmid: 8464931
references.citation: Neuron. 1994 Sep;13(3):713-25
references.pmid: 7917301
references.citation: Cancer Res. 2002 Feb 15;62(4):1205-12
references.pmid: 11861405
references.citation: Respir Physiol. 2001 Dec;129(1-2):71-81
references.pmid: 11738647
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Oncologist. 2002;7(1):17-33
references.pmid: 11854544
references.citation: Cancer Res. 1999 Sep 1;59(17):4383-91
references.pmid: 10485487
references.citation: News Physiol Sci. 1999 Oct;14:177-182
references.pmid: 11390847
references.citation: Brain Res. 1998 Apr 6;789(1):32-9
references.pmid: 9602043
references.citation: Clin Cancer Res. 2000 Jun;6(6):2513-20
references.pmid: 10873107